Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043100 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Raju Das und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dongguk University College of Medicine, Gyeongju 38067, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Dongguk University Research Program.
Abstract (Originalsprache)
Shikonin, a phytochemical present in the roots of Lithospermum erythrorhizon, is well-known for its broad-spectrum activity against cancer, oxidative stress, inflammation, viruses, and anti-COVID-19 agents. A recent report based on a crystallographic study revealed a distinct conformation of shikonin binding to the SARS-CoV-2 main protease (Mpro), suggesting the possibility of designing potential inhibitors based on shikonin derivatives. The present study aimed to identify potential shikonin derivatives targeting the Mpro of COVID-19 by using molecular docking and molecular dynamics simulations. A total of 20 shikonin derivatives were screened, of which few derivatives showed higher binding affinity than shikonin. Following the MM-GBSA binding energy calculations using the docked structures, four derivatives were retained with the highest binding energy and subjected to molecular dynamics simulation. Molecular dynamics simulation studies suggested that alpha-methyl-n-butyl shikonin, beta-hydroxyisovaleryl shikonin, and lithospermidin-B interacted with two conserved residues, His41 and Cys145, through multiple bonding in the catalytic sites. This suggests that these residues may effectively suppress SARS-CoV-2 progression by inhibiting Mpro. Taken together, the present in silico study concluded that shikonin derivatives may play an influential role in Mpro inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Dongguk University College of Medicine, Gyeongju 38067, Republic of Korea.
- Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.
- Department of New Biology, Daegu Gyeongbuk Institute of Science and Technology, Daegu 42988, Republic of Korea.
- New Drug Development Center, Daegu Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea.
- Channelopathy Research Center (CRC), Dongguk University College of Medicine, 32 Dongguk-ro, Goyang 10326, Republic of Korea.
ORCID-Profile: Yohan Seo
Förderung
- National Research Foundation of Korea
- Dongguk University Research Program
Zitieren
APA
Das, R., Habiba, S. U., Dash, R., Seo, Y., & Woo, J. (2023). Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043100
Vancouver
Das R, Habiba SU, Dash R, Seo Y, Woo J. Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043100
BibTeX
@article{Das2023,
author = {Das, Raju and Habiba, Sarmin Ummey and Dash, Raju and Seo, Yohan and Woo, Joohan},
title = {Unveiling the Potentiality of Shikonin Derivatives Inhibiting SARS-CoV-2 Main Protease by Molecular Dynamic Simulation Studies},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043100}
}
EUVIMED